SEARCH BY
Try For Free 7-Day Free Trial
Axol supplies high-quality human cells especially live human neurons created by stem cell technology, too many of the world’s biggest and best-known pharma companies and research institutions, to be used for medical research, disease modelling, and drug development. Axol was founded in 2013 and is based in Easter Bush, United Kingdom.
DEAL STATS | # |
---|---|
Overall | 2 of 2 |
Sector (Life Science) | 2 of 2 |
Type (Add-on Acquisition) | 1 of 1 |
Country (France) | 1 of 1 |
Year (2024) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-03-17 |
Censo
Roslin, United Kingdom Censo is a cell biology CRO with focused expertise in iPSC-related technologies. The company creates relevant, customizable human neurological and inflammatory disease models with induced pluripotent stem cells (iPSC). With deep expertise in neuroscience, immunology, stem cell biology, and gene editing, Censo Biotechnologies specializes in model and assay design for drug discovery. Censo has the ability to select or engineer the desired human genetic background by creating iPSC from patient samples or using CRISPR for gene editing. It has established robust, propriety differentiation protocols for sensory and excitatory cortical neurons, astrocytes, microglia, macrophages, monocytes, and dendritic cells as well as co-cultures. Censo was formed in 2016 and is based in Roslin, United Kingdom. |
Buy | - |